ライフサイエンスコーパス: mucosal biopsy

1 ts and frequent thrombocytopenia complicates mucosal biopsy.

2 ittent diarrhea and can be diagnosed only by mucosal biopsy.

3 began yearly flexible gastroscopy and random mucosal biopsy.

4 stool, intestinal scrapings, and intestinal mucosal biopsies.

5 Lipidomics analyses were performed on mucosal biopsies.

6 ndirect immunofluorescence studies on buccal mucosal biopsies.

7 mplex medical procedures, such as intestinal mucosal biopsies.

8 ed the expression of VEGF-A in human colonic mucosal biopsies.

9 nd demonstrated its use on cryopreserved gut mucosal biopsies.

10 and histopathological evaluation of gastric mucosal biopsies.

11 tinguishable microscopically on the basis of mucosal biopsies.

12 ulfovibrio was enriched both in stool and in mucosal biopsies.

13 Rejection grades were consistently higher in mucosal biopsies.

14 high-powered field (eos/hpf) are detected in mucosal biopsies.

15 ides access to samples of ileal effluent and mucosal biopsies.

16 nty-two patients (54%) had a positive buccal mucosal biopsy; 64% of patients (14/22) demonstrated +DI

17 s found predominantly in CD vs UC intestinal mucosal biopsies; a second band of 24 kDa, consistent wi

18 eukocytes as well as local effects on rectal mucosal biopsies after adding a standardized inflammator

19 average gut mucosal microbiome composition, mucosal biopsies allowed detecting the subtle variations

20 endoscopic swabs did not correlate well with mucosal biopsies along any aspect of the esophagus.

21 anzania over 24 y, alongside comparison with mucosal biopsy analysis in a subset in Zambia.

22 f asthmatic subjects, we performed bronchial mucosal biopsies and airway lavage in seven atopic asthm

23 ls were incubated with supernatants from the mucosal biopsies and analyzed by morphometric and polyme

24 condary clinical measures, histopathology of mucosal biopsies and exploratory, patient reported outco

25 We extracted DNA from rectal mucosal biopsies and measured bacterial levels by quanti

26 pidomic and functional analyses of MFSD2A in mucosal biopsies and primary human intestinal microvascu

27 otein quantitation by ELISA was performed on mucosal biopsy and EST samples.

28 ils per high-power field obtained from sinus mucosal biopsy and managed with neosinus cavity ESS and

29 es 20 to 49 yr, underwent videobronchoscopy, mucosal biopsy, and bronchial lavage to evaluate the air

30 We examined 26 small intestinal mucosal biopsies (AR/NR group; 15/11) obtained from reci

31 In summary, we show that cryopreserved gut mucosal biopsies can be used to overcome the logistical

32 Mucosal biopsies could improve the accuracy in detecting

33 ediators was assessed from medium underlying mucosal biopsy cultures.

34 urveillance relies on serial endoscopies and mucosal biopsies followed by histologic assessment.

35 ns are needed to elucidate the exact role of mucosal biopsies for fVCA patient management.

36 r studies establish the feasibility of using mucosal biopsies for NGS, which should enable the compar

37 ibility of using widely available endoscopic mucosal biopsies for successful NGS, using samples obtai

38 usually 3 to 5 mm in diameter, and an antral mucosal biopsy for subsequent urease testing should be p

39 ix patients with terminal ileum colonoscopic mucosal biopsies (four men, two women; mean age, 43 year

40 Mucosal biopsies from 15 to 20 cm from the anal verge we

41 okine gene expression was also determined in mucosal biopsies from adenoma cases and controls by quan

42 n LP macrophages were identified commonly in mucosal biopsies from CD patients (25/35, 71 %), rarely

43 tion of CD27+ Vdelta2 T cells was present in mucosal biopsies from CD patients and produced elevated

44 entage of apoptosis induced by bile acids in mucosal biopsies from CRC patients with that of noncance

45 Mucosal biopsies from distal esophagus were taken for an

46 Mucosal biopsies from inflamed colon of inflammatory bow

47 s (IECs) and mice, and we measured levels in mucosal biopsies from patients with IBD.

48 We corroborate this finding in mucosal biopsies from patients with ulcerative colitis.

49 We collected mucosal biopsies from the terminal ileum and ascending c

50 Mucosal biopsy from esophagus and rectus confirmed amylo

51 ate <0.05) in the exfoliome, but none in the mucosal biopsies, in response to 60 d of lignan suppleme

52 ation of the bronchial tree and histology of mucosal biopsies indicated no gross or microscopic adver

53 In gut mucosal biopsies, INR had lower fractions of CD4 + T cel

54 In gut mucosal biopsies, INRs had lower fractions of CD4+ T cel

55 In the metagenomic study, colonic mucosal biopsy material was studied from a total of 40 i

56 lyze the gut microbiota profile from colonic mucosal biopsy materials in CLD patients using a metagen

57 Initial mucosal biopsies may not be conclusive, delaying the dia

58 Buccal mucosal biopsy may be considered as an alternative to or

59 We obtained mucosal biopsies (N = 236) collected from terminal ileum

60 Mucosal biopsies obtained before and 4 months after azat

61 NA gene (V4 region) sequencing of 97 colonic mucosal biopsies obtained endoscopically from different

62 (CD) and ulcerative colitis (UC) we obtained mucosal biopsies of children with CD, UC and healthy con

63 sion profiles, and viral loads in intestinal mucosal biopsies of long-term nonprogressor (LTNP) patie

64 mina platform using libraries generated from mucosal biopsies of normal squamous epithelium (NSE), BE

65 lymerase chain reaction (qRT-PCR) in colonic mucosal biopsies of patients from three groups: controls

66 ry cells and in RNA sequencing datasets from mucosal biopsies of patients with EoE and controls.

67 of interleukin-17C, which is induced also in mucosal biopsies of patients with IBD.

68 Mucosal biopsies of the distal esophagus were analyzed u

69 ven when using stool samples rather than the mucosal biopsies required for high discriminatory power

70 alysis of sequential blood samples and colon mucosal biopsies revealed increases in glutathione trans

71 fluorescence were performed on human gastric mucosal biopsy samples and showed that myeloid DCs in H.

72 We analyzed mucosal biopsy samples collected from 101 patients with

73 Small-bowel mucosal biopsy samples from 39 type 1 diabetic patients,

74 various anatomical sites and 13 normal oral mucosal biopsy samples from healthy volunteers with micr

75 eration sequencing (NGS) method from colonic mucosal biopsy samples in CLD and healthy individuals.

76 healthy subjects); 232 fecal samples and 59 mucosal biopsy samples were collected and analyzed by 16

77 epithelial cell lines or cells isolated from mucosal biopsy samples were stimulated with H. pylori, C

78 by colonoscopic surveillance using extensive mucosal biopsy sampling.

79 forming microflora studies of the esophagus, mucosal biopsies should be used for analysis.

80 Five-year mucosal biopsy showed a slight perivascular inflammatory

81 In five patients, duodenal mucosal biopsy showed mild to moderate epithelial injury

82 suspected MMP and paired data on at least a mucosal biopsy specimen for direct immunofluorescence mi

83 equency of detection of H. pylori by gastric mucosal biopsy specimens after 7-30 days of NSAID ingest

84 Mucosal biopsy specimens are a useful means of monitorin

85 We investigated IL-18 levels in gastric mucosal biopsy specimens as well as in isolated gastric

86 e animals were then evaluated clinically and mucosal biopsy specimens assessed by histological and qu

87 ofluorescence analysis of IgG4 in esophageal mucosal biopsy specimens from 24 subjects with eosinophi

88 er in epithelial cells isolated from gastric mucosal biopsy specimens from H. pylori-infected subject

89 urthermore, incubation of P(HEMA-co-SS) with mucosal biopsy specimens from patients with celiac disea

90 ted mediators were secreted spontaneously in mucosal biopsy specimens from patients with EoE than con

91 Mucosal biopsy specimens from patients with IBD retained

92 In this study, rectosigmoid mucosal biopsy specimens from patients with ICL and heal

93 Mucosal biopsy specimens from patients with ulcerative c

94 We examined 73 skin and oral mucosal biopsy specimens immunohistochemically to test t

95 Mucosal biopsy specimens obtained at different time poin

96 Endoscopic mucosal biopsy specimens of Barrett's intestinal metapla

97 Bronchial mucosal biopsy specimens were obtained from 12 asthmatic

98 Mucosal biopsy specimens were obtained from the small bo

99 ncrease in [(3)H]-thymidine incorporation in mucosal biopsy specimens, abolished by the addition of t

100 Explanted airway mucosal biopsy specimens, acquired by bronchoscopy from

101 4 and p11 was measured in sigmoid and rectal mucosal biopsy specimens.

102 e acid-induced apoptosis assay to colorectal mucosal biopsies, the percentage of apoptosis was found

103 ssor were elevated at each of the three oral mucosal biopsy time points examined (day 2 to 4, 14 to 2

104 This work used shotgun metagenomics of mucosal biopsies to explore the microbial communities' c

105 incubated with soluble mediators released by mucosal biopsies to highlight the mechanisms involved in

106 y shown that in vitro exposure of colorectal mucosal biopsies to low concentrations of bile acids pro

107 Mucosal biopsy used to characterize the airway mucosa is

108 eration of the clinical features and colonic mucosal biopsies usually lead to the correct diagnosis a

109 to obtain reparative cells from an olfactory mucosal biopsy via intranasal endoscopy rather than requ

110 t immunofluorescence (DIF) studies in buccal mucosal biopsies was performed.

111 ed to healthy controls, while cathepsin S in mucosal biopsies was unchanged.

112 Upper gastrointestinal endoscopy-guided mucosal biopsy was negative for malignancy.

113 Mucosal biopsies were assayed for disaccharidase activit

114 In addition, previous gastric and mucosal biopsies were assessed for mast cell and eosinop

115 nd postintervention stool samples and rectal mucosal biopsies were collected and used to quantify cal

116 Colon mucosal biopsies were collected from 30 patients with ac

117 As a pathologic correlate, mucosal biopsies were evaluated for the presence of vasc

118 ving grapefruit juice, small bowel and colon mucosal biopsies were obtained endoscopically, oral felo

119 Mucosal biopsies were obtained from the graft at weeks 0

120 In the later period of the review, antral mucosal biopsies were performed through the juxtapyloric

121 Endobronchial mucosal biopsies were stained with Periodic Acid Schiff-

122 Three months after randomization, gastric mucosal biopsies were taken for H. pylori culture and hi

123 Mucosal biopsies were taken from 35 patients with CD, 9

124 Oral mucosal biopsies were used for measurement of CD11c, CD3

125 onic ulcerative colitis and enable 'smarter' mucosal biopsy when combined with chromoendoscopy.

126 duced damage and impaired closure of colonic mucosal biopsy wounds, which coincided with impaired neu